Ristan M. Greer, Helen M. Buntain, Peter J. Lewindon, Claire E

Slides:

Advertisements

Similar presentations

Cheryl Cameron, Mark W. Lodes, William M. Gershan

Advertisements

The prevalence of “risky behaviour” in adults with cystic fibrosis

Serum matrix metalloproteinases in adult CF patients: Relation to pulmonary exacerbation Martin Roderfeld, Timo Rath, Richard Schulz, Werner Seeger,

Treatment compliance in children and adults with Cystic Fibrosis

Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus Magnus Hillman, Leif Eriksson, Lena Mared, Karin Helgesson,

Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients Karen.

Towards an individualized protocol for workload increments in cardiopulmonary exercise testing in children and adolescents with cystic fibrosis H.J.

Abaigeal D. Jackson, Christopher H. Goss Journal of Cystic Fibrosis

Peter R. Mueller-Abt, Kieran J. Frawley, Ristan M. Greer, Peter J

How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF? Sarah P. Cohen, David M. Orenstein

Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H

Development of a quantitative immunofluorescence assay for detection of Stenotrophomonas maltophilia antibodies in patients with cystic fibrosis P. Gonçalves.

Single high-dose oral vitamin D3 (stoss) therapy — A solution to vitamin D deficiency in children with cystic fibrosis? Darren Shepherd, Yvonne Belessis,

Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study Doug L. Forrester, Alan J. Knox,

Laura Viviani, Baroukh M. Assael, Eitan Kerem

Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease

Cirrhosis and other liver disease in cystic fibrosis

Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin

The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population Brandie D. Wagner, Frank J. Accurso,

Controlled clinical trials in cystic fibrosis — are we doing better?

Adherence to nebulised therapies in adolescents with cystic fibrosis is best on week- days during school term-time Rosemary Ball, Kevin W. Southern, Pamela.

Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar

Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox

D.J. Serisier, M.P. Carroll Journal of Cystic Fibrosis

The Journal of Cystic Fibrosis: Sunny perspectives

Vitamin A and lung function in CF

Ghrelin and leptin levels in young adults with cystic fibrosis: Relationship with body fat Charilaos Stylianou, Assimina Galli-Tsinopoulou, George Koliakos,

A.H. Gifford Journal of Cystic Fibrosis

Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis Elizabeth F. Shead, Charles S. Haworth,

Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis Sanja Stanojevic, Valerie Waters, Joseph L.

M. Al-Aloul, M. Jackson, G. Bell, M. Ledson, M. Walshaw

Cystic fibrosis related diabetes in an extremely young patient

Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis

Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor Meredith C. Fidler, Jack Beusmans, Paul Panorchan,

E. Tschiedel, H. Grasemann, F. Ratjen Journal of Cystic Fibrosis

Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?

Depression and anxiety in adolescents and adults with cystic fibrosis in the UK: A cross- sectional study Alistair J.A. Duff, Janice Abbott, Carolyn Cowperthwaite,

Nasal polyposis in lung transplant recipients with cystic fibrosis

Hypertriglyceridemia is associated with insulin levels in adult cystic fibrosis patients Marie-Claire Ishimo, Linda Belson, Sophie Ziai, Emile Levy, Yves.

Narelle S. Cox, Jennifer Follett, Karen O. McKay

Inflammatory and immunological biomarkers are not related to survival in adults with Cystic Fibrosis K.L. Moffitt, S.L. Martin, A.M. Jones, A.K. Webb,

Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis Geraint B. Rogers, Lucas R. Hoffman,

Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.

Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention H. White, K. Pollard, C. Etherington, I. Clifton,

Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa Karen O. McKay, Peter J. Cooper, Peter P. van.

Higher risk of hospitalization among females with cystic fibrosis

Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005 F.A. Millar, N.J. Simmonds, M.E. Hodson Journal.

Mark R. Johnson, Thomas W. Ferkol, Ross W. Shepherd

H. White, A.M. Morton, S.P. Conway, D.G. Peckham

J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer

Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid

Voriconazole therapy in children with cystic fibrosis

Antibiograms of resistant Gram-negative bacteria from Scottish CF patients F.M. MacKenzie, S.V. Smith, K.E. Milne, K. Griffiths, J. Legge, I.M. Gould

Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis Hanne Vebert Olesen, Uffe Holmskov, Peter Oluf Schiøtz, Grith Lykke Sørensen

Decreased interleukin-18 expression in BAL cells and peripheral blood mononuclear cells in adult cystic fibrosis patients Hans-Peter Hauber, Inga S Beyer,

D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher

The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation C. Etherington,

CFTR modulators and pregnancy: Our work has only just begun

Beta-lactam allergy in adults with cystic fibrosis

N Dauletbaev, K Viel, R Buhl, T.O.F Wagner, J Bargon

Cheryl Cameron, Mark W. Lodes, William M. Gershan

Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz Journal of Cystic Fibrosis

Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub

David Adeboyeku, Sandra Scott, Margaret E. Hodson

Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern?

Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L

Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis D.J. Touw, A.J. Knox,

Absence of a gender gap in survival

R. D. Gray, M. Imrie, A. C. Boyd, D. Porteous, J. A. Innes, A. P

H. White, A.M. Morton, D.G. Peckham, S.P. Conway

Presentation transcript:

Vitamin A levels in patients with CF are influenced by the inflammatory response Ristan M. Greer, Helen M. Buntain, Peter J. Lewindon, Claire E. Wainwright, Julia M. Potter, Joseph C. Wong, Paul W. Francis, Jennifer A. Batch, Scott C. Bell Journal of Cystic Fibrosis Volume 3, Issue 3, Pages 143-149 (August 2004) DOI: 10.1016/j.jcf.2004.04.003

Fig. 1 Mean (95% CI) serum vitamin A (μmol/l) in control subjects and subjects with CF. Serum vitamin A was not significantly different between control and CF children (1.45, 1.25–1.64, n=25 vs. 1.11, 0.95–1.27, n=39, p=0.08) but higher in control adolescents (1.73, 1.61–1.85, n=65 vs. 1.19, 1.05–1.34, n=45, p<0.0001) and adults (2.08, 1.94–2.22, n=48 vs. 1.50, 1.37–1.63, n=54, p<0.0001) compared with the CF group. Journal of Cystic Fibrosis 2004 3, 143-149DOI: (10.1016/j.jcf.2004.04.003)